The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Exact Sciences Corp (NASDAQ: EXAS) closed at $55.17 up 0.60% from its previous closing price of $54.84. In other words, the price has increased by $0.60 from its previous closing price. On the day, 2.06 million shares were traded.
Ratios:
For a deeper understanding of Exact Sciences Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 53.61. For the most recent quarter (mrq), Quick Ratio is recorded 2.38 and its Current Ratio is at 2.73. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 1.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on April 10, 2025, initiated with a Outperform rating and assigned the stock a target price of $60.
On March 13, 2025, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $52.
On January 23, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $70.Barclays initiated its Overweight rating on January 23, 2025, with a $70 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 13 ’24 when Conroy Kevin T bought 19,500 shares for $51.35 per share. The transaction valued at 1,001,325 led to the insider holds 1,074,191 shares of the business.
Baranick Brian sold 929 shares of EXAS for $65,030 on Oct 08 ’24. The EVP, GM, Precision Oncology now owns 12,758 shares after completing the transaction at $70.00 per share. On Oct 08 ’24, another insider, Baranick Brian, who serves as the Officer of the company, bought 929 shares for $70.00 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.68 while its Price-to-Book (P/B) ratio in mrq is 4.34.
Stock Price History:
Over the past 52 weeks, EXAS has reached a high of $72.83, while it has fallen to a 52-week low of $39.97. The 50-Day Moving Average of the stock is 11.97%, while the 200-Day Moving Average is calculated to be -1.74%.
Shares Statistics:
A total of 188.59M shares are outstanding, with a floating share count of 185.86M. Insiders hold about 1.47% of the company’s shares, while institutions hold 97.60% stake in the company.
